FDA Announces Plans for Advancing Cell and Gene Therapies

Drug Industry Daily
In anticipation of a surge of investigational new drug applications for cell and gene therapies in the next few years, FDA Commissioner Scott Gottlieb and CBER Director Peter Marks on Tuesday announced plans to issue new guidance to advance their development.

To View This Article:


Subscribe To Drug Industry Daily